资讯
1 个月
GlobalData on MSNMedtronic announces two-year trial outcomes of Evolut TAVRIn addition, the findings demonstrated “comparable” composite results of death, disabling stroke, and heart failure ...
1 个月
Zacks.com on MSNPositive Trial Data on Evolut TAVR Likely to Support MDT StockThe two-year results highlighted the continued superior performance of the Evolut TAVR valve in patients with a small aortic ...
In patients with aortic stenosis and a small aortic annulus, results showed comparable composite outcome of mortality, disabling stroke, and heart failure hospitalization, and continued superior ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果